Overcoming resistance to CDK4/6 inhibitors in ER+ breast cancer via ctDNA VJOncology 1:08 2 years ago 471 Скачать Далее
Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancer European Society for Medical Oncology (ESMO) 4:50 1 year ago 1 342 Скачать Далее
CDK 4/6 Inhibitors for Patients with Recurrent ER+/HER2- Breast Cancer: 2023 Best of Breast Total Health | Oncology 2:19 1 year ago 270 Скачать Далее
Investigating mechanisms of resistance to CDK4/6 inhibitors VJOncology 0:50 1 year ago 150 Скачать Далее
CDK4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer VJOncology 5:01 4 years ago 698 Скачать Далее
Expert Perspectives: CDK 4/6 Inhibitors for ER+ Breast Cancer: Current Data and Clinical Use HMP Education 17:54 8 years ago 4 809 Скачать Далее
The use of frontline CDK4/6 inhibitors + endocrine therapy in metastatic breast cancer VJOncology 2:11 1 year ago 777 Скачать Далее
Assessing elacestrant in ctDNA-positive patients with ER+ breast cancer VJOncology 3:01 2 years ago 210 Скачать Далее
Dr. Rugo on Resistance to CDK4/6 Inhibitors in HR+ Breast Cancer OncLive 1:22 5 years ago 149 Скачать Далее
CDK4/6 Inhibitors & Endocrine Therapy: Treatment Resistance Targeted Oncology 6:46 5 years ago 275 Скачать Далее
Dr. Jhaveri on Acquired Resistance to CDK 4/6 Inhibitors in Breast Cancer OncLive 1:13 6 years ago 541 Скачать Далее
“I am at risk for breast cancer, can ctDNA help detect and manage my disease more effectively? Doctor Grew Explains Cancer 0:53 8 days ago 16 Скачать Далее
Reflecting on the use of CDK4/6 inhibitors in HR+ breast cancer VJOncology 1:51 3 years ago 107 Скачать Далее
Interferon-Response Gene Signatures and Resistance to CDK 4/6 Inhibitors in Breast Cancer PracticeUpdate 4:56 3 years ago 40 Скачать Далее
Treatment Following Relapse on CDK4/6 Inhibitors Targeted Oncology 4:39 5 years ago 123 Скачать Далее
